Education
About Us
Working with TipRanks
Follow Us
Aryzta ADR (ARZTY)
OTHER OTC:ARZTY
Top Page
Aryzta ADR
(OTC:ARZTY)
Select Model
Select Model
Rating:66Neutral
Price Target:
$8.00
▲(24.61% Upside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by improving fundamentals—sustained profitability and positive free cash flow—tempered by revenue decline, some margin pressure, and still-elevated leverage. Valuation is supportive with a moderate P/E (~12), while technicals are mixed (below the 200DMA and slightly below the 20DMA, with mostly neutral momentum). Earnings call commentary adds confidence via reaffirmed targets and balance-sheet actions, but near-term execution risks (input costs, retail softness, restructuring, and H2-weighted cash flow) cap the score.
Positive Factors
Consistent free cash flow generation
Sustained free cash flow (~€120m in FY2025) provides durable funding for debt reduction, capex and targeted reinvestment. Reliable cash conversion supports deleveraging plans and a capital-return policy while giving management flexibility to fund transformation and margins improvements over the next 2–6 months.
ROIC materially above WACC
A ROIC ~12.1% versus WACC ~8% indicates the core bakery operations generate economic value and justify reinvestment. This structural outperformance supports sustainable returns, underpins management's ability to pursue savings and growth investments, and provides a buffer versus capital cost pressure over the medium term.
Innovation driving revenue mix
Innovation contributing nearly one-fifth of revenue signals durable product development and differentiation. This improves price/mix dynamics, supports margin resilience, and helps the company access premium channels and long-term contracts—strengthening competitive positioning beyond short-term demand swings.
Negative Factors
Net leverage above target range
Leverage at ~2.6x limits financial flexibility and increases refinancing and interest-rate exposure. Until deleveraging reaches the 1.5–2x target and core equity improves, the company faces constraints on dividend/buyback policy, higher financing costs and reduced resilience to input-cost or demand shocks over the coming months.
Input-cost driven margin pressure
Substantial commodity and labor inflation shaved nearly 340bps off margins, showing structural exposure to raw-material cycles. Absent sustained pricing or structural savings, margins remain vulnerable; the planned savings program is positive but timing means near-term margin volatility may persist into the medium term.
Flat retail performance
Flat retail sales indicate a persistent headwind in a key channel, limiting diversification of growth. Continued weakness or mixed retail trends could slow top-line recovery and put pressure on volume-dependent margins, forcing heavier reliance on foodservice/QSR and cost cuts to sustain overall growth.
Aryzta ADR (ARZTY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.86B
Dividend YieldN/A
Average Volume (3M)509.00
Price to Earnings (P/E)12.0
Beta (1Y)0.85
Revenue Growth4.35%
EPS Growth-93.15%
CountryUS
Employees7,654
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.28
Shares Outstanding248,276,440
10 Day Avg. Volume67
30 Day Avg. Volume509
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)2.34
Price to Sales (P/S)0.61
P/FCF Ratio7.84
Enterprise Value/Market Cap1.21
Enterprise Value/Revenue1.02
Enterprise Value/Gross Profit3.92
Enterprise Value/Ebitda8.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aryzta ADR Business Overview & Revenue Model
Company DescriptionARYZTA AG provides frozen B2B baking solutions in Europe, Asia, Australia, and New Zealand. It offers pastries, cookies, donuts, muffins, buns, bread rolls and artisan loaves, sweet baked and morning goods, and savory and other products. The company also provides asset management services; and distributes food products. It serves large retail, convenience, and independent retailers, as well as quick service restaurants and other foodservice customers. In addition, it sells product under the Hiestaud, Mette Munk, Pre Pain, Cuisine de France, Coup de Pates, La Brea, Oits Spunkmeyer, and Fornetti brands. The company has 26 bakeries in 27 countries. ARYZTA AG was founded in 1897 and is based in Schlieren, Switzerland.
How the Company Makes MoneyARYZTA makes money primarily by manufacturing and selling bakery products in business-to-business channels. Its main revenue stream is the sale of bread and specialty bakery items (e.g., buns, rolls, artisan breads, pastries) to (1) retail customers (such as supermarkets) that sell products under private label and/or finished in-store, and (2) foodservice customers, including restaurant chains and other institutional buyers that require consistent, standardized bakery inputs. A key component of its model is producing frozen and par-baked items at scale, which customers can store and then bake/finish as needed, improving freshness at point of sale while simplifying customer operations; ARYZTA captures revenue through product volume sold under supply agreements and recurring replenishment demand. Revenue is also supported by long-term commercial relationships and contract-like supply arrangements with large customers where product specifications, service levels, and logistics capabilities (e.g., reliable delivery of frozen bakery) are critical differentiators. Specific details on significant partnerships, customer concentration, pricing mechanics, or segment-level revenue breakdown for the ADR ticker ARZTY are null.
Aryzta ADR Earnings Call Summary
Earnings Call Date:Mar 02, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Aug 17, 2026
Earnings Call Sentiment Positive
The call presents a predominantly constructive operational and financial picture: revenue growth, EBITDA above guidance, strong free cash flow and ROIC above WACC are clear positives. Headwinds include input-cost-driven margin pressure, flat retail performance, remaining leverage above target and anticipated restructuring costs in 2026. Management has credible mitigation plans (savings program, digital investments, hybrid repayment) and a path to normalized capital structure, but some near-term execution and timing risks remain.Q4-2025 Updates
Positive Updates
Revenue and Organic Growth
Revenue of EUR 2.223 billion in FY2025 with organic growth of 1.5%, supported by volume, mix (0.5%) and pricing (1%).
EBITDA Above Guidance
EBITDA of EUR 306.9 million (13.8% margin), which was above the October guidance and demonstrates resilience in a challenging environment.
Strong Free Cash Flow and Cash Conversion
Free cash flow of EUR 120 million, representing a cash conversion of almost 40% of EBITDA; working capital improvements (trade NWC reduced to 0.2% of revenue from 0.7% in 2024) were major contributors.
Value Creation Metrics
Return on invested capital (ROIC) of 12.1%, well above the group's WACC of ~8%, and earnings per share increased by 5.7% to EUR 4.25.
Balance Sheet and Financing Progress
Leverage reduced to 2.6x; announced repayment of remaining hybrid principal CHF 144.3 million at end-April 2026; total financing costs improved to EUR 41.6 million (over EUR 4 million better than low end guidance), with hybrid buyback contributing ~EUR 23 million of savings.
Innovation and Portfolio Strength
Innovation accounted for 19% of revenue and was accretive to growth, supporting margin resilience and product mix.
Regional Outperformance and Operational Progress
Rest of World delivered 2.9% organic growth and an EBITDA margin improvement of 110 basis points to 20.9%; Europe delivered 1.3% organic growth with broad-based contribution from Ireland, France, Germany and Poland.
Cost Savings and Transformation Roadmap
Midterm program targets net savings of EUR 20–30 million (gross EUR 40–60 million from operations/procurement/structure) with ~EUR 20–30 million to be reinvested in digital/AI; identified ~EUR 10 million gross annual structural cost reduction from organizational alignment.
Negative Updates
Margin Pressure from Input Costs
Input cost inflation (labor, butter, protein, chocolate) reduced gross margin by ~290 basis points; FX and other elements further negative by ~50 basis points, leaving EBITDA margin ~80 basis points below prior year.
Retail Performance Weakness
Retail revenue was broadly flat year-over-year with mixed pricing and volume trends across businesses; retail presented a more challenging performance relative to foodservice and QSR.
Leverage and Equity Ratio Not Yet at Targets
Net leverage at 2.6x remains above the stated midterm target range of 1.5–2x; core equity at 21.1% (target ~30% longer term), meaning balance sheet normalization is in progress but incomplete.
Restructuring Costs and One-Offs Headwinds in 2026
Planned restructuring and organizational alignment will incur one-off costs in 2026 (savings to be realized more fully in 2027); specifics on FTE reductions were not disclosed.
Back‑loaded Cash Flow and Near‑term CapEx Impact
Management expects 2026 cash flow to be H2-weighted, with near-term cash outflows for Perth factory completion and a major cooling system installation affecting H1 cash generation.
Uncertainty on Immediate Capital Return
Board will publish capital allocation policy during 2026; no immediate commitment to dividends or buybacks until balance sheet and equity targets progress, creating timing uncertainty for shareholder returns.
Company Guidance
ARYZTA confirmed it remains on track to deliver its mid‑term plan, guiding to low‑ to mid‑single‑digit organic growth with continued EBITDA/EBIT improvement toward targets (mid‑term EBITDA margin ≥15% and EBIT margin ≥9%), CapEx of 3.5–4.5% of revenue, and total net debt leverage of 1.5–2.0x while publishing a 2026 capital‑return policy. Management expects sustained strong free cash‑flow generation (FY‑2025 FCF €120m; cash conversion ~40% of EBITDA) with 2026 FCF to be H2‑weighted but broadly similar, and balance‑sheet improvement including repurchase of the remaining CHF144.3m hybrid end‑April, reducing leverage from 2.6x (2025) and increasing core equity from 21.1% toward ~30% by year‑end. 2026 financing costs are expected at €40–43m (FY‑2025 actual €41.6m, with ~€23m benefit from the hybrid buyback and ~37% interest exposure hedged); operational savings are targeted at €20–30m net (€40–60m gross from ops/procurement/structure, with ~€10m of gross structural annual savings identified), some restructuring costs to be incurred in 2026, and management reiterated ROIC of 12.1% in 2025 (vs WACC ~8%) and FY‑2025 revenue €2.223bn, organic growth 1.5%, EBITDA €306.9m (13.8% margin) and EPS €4.25 (+5.7%).Aryzta ADR Financial Statement Overview
Summary
Turnaround is established with sustained profitability since 2022 and solid 2025 margins (gross ~31.6%, EBITDA ~13.8%, net ~5.1%) plus positive operating cash flow and free cash flow. Offsetting this, 2025 revenue declined (~-4.1%), operating margins softened vs 2024, free cash flow dipped (~-6.4%), and leverage remains a constraint despite improvement (debt-to-equity ~1.29).Income Statement
Profitability has improved materially versus 2020–2021 losses, with positive net income since 2022 and solid 2025 margins (gross margin ~31.6%, EBITDA margin ~13.8%, net margin ~5.1%). However, growth has turned choppy: revenue declined ~4.1% in 2025 after modest growth in 2024, and operating profitability (EBIT/EBITDA margins) eased versus 2024—suggesting some recent margin pressure despite the stronger gross margin.73
Positive
Balance Sheet
Leverage is the key constraint. Debt-to-equity remains elevated at ~1.29 in 2025 (improved from ~1.81 in 2024 but higher than 2021–2023 levels), which reduces financial flexibility. Offsetting this, returns on equity are strong in 2024–2025 (~28.7% and ~19.5%), and total assets are relatively stable—indicating a healthier earnings base than earlier years, but with a balance sheet that has become more debt-heavy than in the 2021–2023 period.57
Neutral
Cash Flow
Cash generation is positive and meaningful (2025 operating cash flow ~$248M and free cash flow ~$165M), supporting debt service and reinvestment. Still, free cash flow declined in 2025 (about -6.4% growth) and cash conversion is only moderate, with free cash flow running at ~67% of net income in 2025 (similar in 2024). Overall cash flow is healthier than 2020–2021, but not consistently strengthening year-over-year.62
Positive
| Breakdown | Dec 2025 | Dec 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.14B | 2.19B | 2.12B | 1.76B | 1.53B |
| Gross Profit | 675.16M | 469.20M | 392.30M | 318.50M | 252.50M |
| EBITDA | 293.83M | 341.00M | 280.40M | 170.30M | 182.90M |
| Net Income | 107.87M | 129.60M | 112.00M | 900.00K | -235.80M |
Balance Sheet | |||||
| Total Assets | 1.89B | 1.91B | 1.97B | 2.08B | 2.06B |
| Cash, Cash Equivalents and Short-Term Investments | 68.57M | 77.10M | 130.80M | 245.80M | 170.90M |
| Total Debt | 714.20M | 816.40M | 524.90M | 535.80M | 373.30M |
| Total Liabilities | 1.33B | 1.46B | 1.17B | 1.15B | 961.60M |
| Stockholders Equity | 552.86M | 452.10M | 793.30M | 932.40M | 1.10B |
Cash Flow | |||||
| Free Cash Flow | 165.31M | 204.60M | 197.30M | 116.80M | 300.00K |
| Operating Cash Flow | 247.53M | 298.90M | 251.40M | 200.10M | 84.30M |
| Investing Cash Flow | -92.50M | -93.40M | -60.10M | 8.90M | 633.20M |
| Financing Cash Flow | -158.97M | -230.60M | -299.10M | -143.40M | -976.00M |
Aryzta ADR Technical Analysis
Positive
6.42
Price Trends
7.11
Positive
6.70
Positive
7.91
Negative
Market Momentum
0.14
Positive
52.56
Neutral
3.48
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARZTY, the sentiment is Positive. The current price of 6.42 is below the 20-day moving average (MA) of 7.55, below the 50-day MA of 7.11, and below the 200-day MA of 7.91, indicating a neutral trend. The MACD of 0.14 indicates Positive momentum. The RSI at 52.56 is Neutral, neither overbought nor oversold. The STOCH value of 3.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ARZTY.
Aryzta ADR Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $3.17B | 21.37 | 12.35% | ― | 16.34% | 177.51% | |
66 Neutral | $1.86B | 12.02 | 23.34% | ― | 4.35% | -93.15% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $1.30B | 19.23 | 5.04% | ― | 8.98% | -26.29% | |
62 Neutral | $1.39B | 11.70 | 5.35% | 5.40% | 1.44% | 8.29% | |
54 Neutral | $1.75B | 27.30 | 6.02% | 9.15% | 0.26% | -19.45% |
* Consumer Defensive Sector Average
ARZTY
Aryzta ADR
7.51
-2.09
-21.79%
FLO
Flowers Foods
8.26
-8.49
-50.69%
SMPL
Simply Good Foods
14.05
-19.35
-57.93%
FRPT
Freshpet
64.68
-24.08
-27.13%
NOMD
Nomad Foods
9.77
-8.58
-46.75%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.